The headline you’ve probably read more than once, including here on A Sweet Life, is one of outrage surrounding rumors o…
Insulin
Just How Quick is Fiasp, Novo Nordisk’s Faster-Acting Insulin?
Fiasp, a new, faster-acting insulin from Novo Nordisk, is generating a lot of interest and carries with it much potentia…
A New Approach to Smart Insulin
Imagine a molecular container where the building blocks are glued together with a substance that’s sensitive to glucose:…
Keep Your Insulin at a Safe Temperature with MedAngel
I recently had the opportunity to chat with MedAngel’s founder, Amin Zayani. MedAngel is a device that helps people keep…
Fiasp, New Fast-Acting Insulin, Now Available in Canada
A faster acting mealtime insulin is now approved and available in Canada.
Novo Nordisk Canada Inc. announced that Fiasp…
Novo Nordisk and CVS Offer Discounted, But Inferior, Insulin
This week, Novo Nordisk and CVS Health announced a new program that will offer discounts on insulin, a life-sustaining d…
People With Diabetes Sue Insulin Makers Over Rising Prices
Eleven people living with diabetes, with the support of the law firm Hagens Berman, have filed a class action lawsuit in…
How Afrezza Inhaled Insulin Makes My Life Better
The first time I took Afrezza––an inhalable fast-acting insulin––in public, it was at Wildair, a small, hip restaurant i…
Lilly Announces Program to Provide Insulin at Discounted Prices
Starting January 1, people who pay the highest out-of-pocket prices for insulin, such as those who pay full retail price…
MannKind Markets Afrezza to People with Type 1 Diabetes
The maker of inhaled insulin Afrezza is betting that relaunching their product and making it a success depends less on d…